Delwin L. Bokelman

947 total citations
23 papers, 764 citations indexed

About

Delwin L. Bokelman is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Delwin L. Bokelman has authored 23 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Delwin L. Bokelman's work include Pregnancy and preeclampsia studies (3 papers), Computational Drug Discovery Methods (3 papers) and Plant biochemistry and biosynthesis (3 papers). Delwin L. Bokelman is often cited by papers focused on Pregnancy and preeclampsia studies (3 papers), Computational Drug Discovery Methods (3 papers) and Plant biochemistry and biosynthesis (3 papers). Delwin L. Bokelman collaborates with scholars based in United States. Delwin L. Bokelman's co-authors include J. S. Macdonald, Richard T. Robertson, Ronald J. Gerson, Douglas J. Kornbrust, David H. Minsker, Alfred W. Alberts, S. Prahalada, Michelle W. Kloss, R Jensen and Henry L. Allen and has published in prestigious journals such as Cancer Research, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

Delwin L. Bokelman

19 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delwin L. Bokelman United States 13 249 229 120 88 80 23 764
Nils‐Erik Huseby Norway 17 116 0.5× 241 1.1× 72 0.6× 66 0.8× 24 0.3× 36 888
Arnaldo Capelli Italy 20 325 1.3× 346 1.5× 77 0.6× 47 0.5× 22 0.3× 51 1.3k
Takeyuki Monna Japan 18 155 0.6× 313 1.4× 87 0.7× 122 1.4× 18 0.2× 122 1.4k
Sverre Skrede Norway 20 232 0.9× 484 2.1× 31 0.3× 23 0.3× 56 0.7× 50 1.1k
Hyung-Lae Lee South Korea 13 134 0.5× 370 1.6× 75 0.6× 28 0.3× 40 0.5× 35 702
Xiulong Song United States 18 160 0.6× 259 1.1× 80 0.7× 72 0.8× 71 0.9× 25 865
J Ahlberg Sweden 19 593 2.4× 230 1.0× 46 0.4× 45 0.5× 41 0.5× 49 1.4k
Basil A. Bradlow South Africa 18 209 0.8× 175 0.8× 34 0.3× 59 0.7× 43 0.5× 40 1.2k
J Fischbein United States 4 153 0.6× 335 1.5× 171 1.4× 16 0.2× 22 0.3× 7 876

Countries citing papers authored by Delwin L. Bokelman

Since Specialization
Citations

This map shows the geographic impact of Delwin L. Bokelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delwin L. Bokelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delwin L. Bokelman more than expected).

Fields of papers citing papers by Delwin L. Bokelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delwin L. Bokelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delwin L. Bokelman. The network helps show where Delwin L. Bokelman may publish in the future.

Co-authorship network of co-authors of Delwin L. Bokelman

This figure shows the co-authorship network connecting the top 25 collaborators of Delwin L. Bokelman. A scholar is included among the top collaborators of Delwin L. Bokelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delwin L. Bokelman. Delwin L. Bokelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choy, Wai Nang, Kathryn Kersey, Ziyang Zhong, et al.. (2007). Preclinical safety profile of tanespimycin (KOS-953) - a heat shock protein 90 (Hsp90) inhibitor. Cancer Research. 67. 1568–1568. 1 indexed citations
2.
Prahalada, S., Kevin P. Keenan, Lea R. Gordon, et al.. (1994). Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor. Urology. 43(5). 680–685. 32 indexed citations
3.
Gerson, Ronald J., et al.. (1991). The Toxicity of a Fluorinated-Biphenyl HMG-CoA Reductase Inhibitor in Beagle Dogs. Toxicological Sciences. 16(2). 320–329. 1 indexed citations
4.
Gerson, Ronald J., J. S. Macdonald, Alfred W. Alberts, et al.. (1990). On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors. Experimental Eye Research. 50(1). 65–78. 86 indexed citations
5.
Gerson, Ronald J., et al.. (1989). Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme a reductase inhibitors. The American Journal of Medicine. 87(4A). S28–S38. 117 indexed citations
6.
Macdonald, J. S., Ronald J. Gerson, Douglas J. Kornbrust, et al.. (1988). Preclinical evaluation of lovastatin. The American Journal of Cardiology. 62(15). J16–J27. 163 indexed citations
7.
Clark, Robert L., Richard T. Robertson, C. P. Peter, et al.. (1986). Association between Adverse Maternal and Embryo-Fetal Effects in Norfloxacin-Treated and Food-Deprived Rabbits. Toxicological Sciences. 7(2). 272–286. 3 indexed citations
8.
Macdonald, J. S., et al.. (1985). Imipenem/Cilastatin sodium (MK-0787/MK-0791) の安全性に関する研究 (第2報):ラットにおける静脈内または皮下投与による亜急性ならびに慢性毒性試験. Chemotherapy. 33(4). 129–180. 1 indexed citations
9.
Macdonald, J. S., et al.. (1985). Imipenem/Cilastatin sodium (MK-0787/MK-0791) の安全性に関する研究 (第3報):アカゲザルにおける亜急性および慢性毒性試験. Chemotherapy. 33(4). 181–206. 1 indexed citations
10.
Macdonald, J. S., et al.. (1985). Imipenem/Cilastatin sodium (MK-0787/MK-0791) の安全性に関する研究 (第3報). Chemotherapy. 33. 181–206. 1 indexed citations
11.
Clark, Robert L., Richard T. Robertson, David H. Minsker, et al.. (1984). Diflunisal‐induced maternal anemia as a cause of teratogenicity in rabbits. Teratology. 30(3). 319–332. 34 indexed citations
12.
Minsker, David H., J. S. Macdonald, Richard T. Robertson, & Delwin L. Bokelman. (1983). Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase. Teratology. 28(3). 449–456. 89 indexed citations
13.
Jensen, R, et al.. (1982). Spontaneous tumors in control F344 and Charles River-CD rats and Charles River CD-1 and B6C3HF1 mice. Toxicology Letters. 11(1-2). 103–110. 61 indexed citations
14.
Minsker, David H., et al.. (1982). Exposure of Rats to Lead Nitrate in utero or Postpartum; Effects on Morphology and Behavior. Neonatology. 41(3-4). 193–203. 7 indexed citations
15.
Robertson, Richard T., et al.. (1981). Potassium loss as a causative factor for skeletal malformations in rats produced by indacrinone: A new investigational loop diuretic. Toxicology and Applied Pharmacology. 60(1). 142–150. 25 indexed citations
16.
Robertson, Richard T., et al.. (1980). Effects of prenatal exposure to chlorpromazine on postnatal development and behavior of rats. Toxicology and Applied Pharmacology. 53(3). 541–549. 34 indexed citations
17.
Minsker, David H., et al.. (1979). Effects of lead exposure in utero or post partum on brain histo morphology and behavior in rat offspring. Birth Defects Research. 19(2). 40. 1 indexed citations
18.
Bagdon, Walter, et al.. (1978). Morphologic abnormalities in potassium-deficient dogs.. PubMed. 93(1). 103–16. 9 indexed citations
19.
Bokelman, Delwin L., et al.. (1971). Strain-dependent renal toxicity of a nonsteroid antiinflammatory agent. Toxicology and Applied Pharmacology. 19(1). 111–124. 25 indexed citations
20.
Vogin, Eugene E., Helen R. Skeggs, Delwin L. Bokelman, & Paul A. Mattis. (1967). Liver function: Postprandial urea nitrogen elevation and indocyanine green clearance in the dog. Toxicology and Applied Pharmacology. 10(3). 577–585. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nils‐Erik Huseby Breakdown of academic impact, for papers by Arnaldo Capelli Breakdown of academic impact, for papers by Takeyuki Monna Breakdown of academic impact, for papers by Sverre Skrede Breakdown of academic impact, for papers by Hyung-Lae Lee Breakdown of academic impact, for papers by Xiulong Song Breakdown of academic impact, for papers by J Ahlberg Breakdown of academic impact, for papers by Basil A. Bradlow Breakdown of academic impact, for papers by J Fischbein
Rankless by CCL
2026